Sign in Sign up for free

Last updated: 3 July 2024 at 9:06pm EST

Louis Silverman Net Worth




The estimated Net Worth of Lou Silverman is at least $3.13 Million dollars as of 10 August 2021. Mr. Silverman owns over 29,921 units of Staar Surgical Co stock worth over $389,332 and over the last 10 years he sold STAA stock worth over $2,514,301. In addition, he makes $230,509 as Independent Chairman of the Board at Staar Surgical Co.

Mr. Silverman STAA stock SEC Form 4 insiders trading

Louis has made over 4 trades of the Staar Surgical Co stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 29,921 units of STAA stock worth $271,982 on 10 August 2021.

The largest trade he's ever made was exercising 29,921 units of Staar Surgical Co stock on 10 August 2021 worth over $271,982. On average, Louis trades about 3,748 units every 146 days since 2014. As of 10 August 2021 he still owns at least 12,845 units of Staar Surgical Co stock.

You can see the complete history of Mr. Silverman stock trades at the bottom of the page.





Louis Silverman biography

Louis E. Silverman serves as Independent Chairman of the Board of the Company. Since February 2014, Mr. Silverman has served as the Chairperson and Chief Executive Officer of privately held Advanced ICU Care, Inc., a health care services company providing tele-ICU monitoring services to hospitals. From June 2012 through February 2014, Mr. Silverman served as a consultant and Board advisor for private equity investors and others regarding health care technology and health care technology service companies, and health care services portfolio investments. From September 2009 through June 2012, Mr. Silverman was Chief Executive Officer of Marina Medical Billing Services, Inc., a revenue cycle management company serving ER physicians nationally. Previously, from September 2008 through August 2009, Mr. Silverman served as President and Chief Executive Officer of Qualcomm-backed health care start-up LifeComm. From August 2000 through August 2008, Mr. Silverman served as the President and Chief Executive officer of Quality Systems, Inc., a publicly traded developer of medical and dental practice management and patient records software. From 1993 through 2000, he served as Chief Operating Officer of CorVel Corporation, a publicly traded national managed care services/technology company. Mr. Silverman earned a B.A. from Amherst College and an M.B.A. from Harvard Business School.

What is the salary of Louis Silverman?

As the Independent Chairman of the Board of Staar Surgical Co, the total compensation of Louis Silverman at Staar Surgical Co is $230,509. There are 11 executives at Staar Surgical Co getting paid more, with Caren Mason having the highest compensation of $3,616,040.



How old is Louis Silverman?

Louis Silverman is 61, he's been the Independent Chairman of the Board of Staar Surgical Co since 2017. There are 7 older and 14 younger executives at Staar Surgical Co. The oldest executive at Staar Surgical Co. is John Moore, 76, who is the Independent Director.

What's Louis Silverman's mailing address?

Lou's mailing address filed with the SEC is C/O ONCOCYTE CORPORATION, 15 CUSHING, IRVINE, CA, 92618.

Insiders trading at Staar Surgical Co

Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal..., and Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.



What does Staar Surgical Co do?

staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl"​. nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad



What does Staar Surgical Co's logo look like?

Staar Surgical Co. logo

Complete history of Mr. Silverman stock trades at Staar Surgical Co and Oncocyte

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
10 Aug 2021 STAA Staar Surgical Co. Lou Silverman
Director
 Option 29,921 $9.09 $271,982
10 Aug 2021
12,845 ↗
24 Jun 2021 STAA Staar Surgical Co. Lou Silverman
Director
 Option 807 $154.96 $125,053
24 Jun 2021
2,924 ↗
1 Mar 2021 STAA Staar Surgical Co. Lou Silverman
Director
 Sale 23,996 $104.78 $2,514,301
1 Mar 2021
2,117 ↗
10 Aug 2015 STAA Staar Surgical Co. Lou Silverman
Director
 Buy 1,500 $8.18 $12,270
10 Aug 2015
6,398 ↗


Staar Surgical Co executives and stock owners

Staar Surgical Co executives and other stock owners filed with the SEC include: